Nang Kuang Pharmaceutical Co., Ltd. (TPE:1752)

Market Cap	3.21B -9.5%
Revenue (ttm)	2.11B -6.2%
Net Income	204.95M -21.4%
EPS	2.02 -21.4%
Shares Out	100.99M
PE Ratio	15.72
Forward PE	n/a
Dividend	1.60 (5.05%)
Ex-Dividend Date	Jul 2, 2026

Volume	19,524
Open	31.40
Previous Close	31.75
Day's Range	31.25 - 31.70
52-Week Range	31.10 - 40.70
Beta	0.13
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 7, 2026

About Nang Kuang Pharmaceutical

Nang Kuang Pharmaceutical Co., Ltd. manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally. The company offers ready to use injections, such as prefilled syringe injections and premixed IV infusions; anti-aging and preventive medicines; chemotherapy and oncology products; and non-PVC IV infusion. It also provides various products in the areas of cardiovascular, gastrointestinal, nervous, musculo-skeletal, and respiratory system, as well as in a...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1963
• Employees: 552
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 1752

Financial Performance

In 2025, Nang Kuang Pharmaceutical's revenue was 2.16 billion, a decrease of -1.71% compared to the previous year's 2.20 billion. Earnings were 244.41 million, an increase of 0.41%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 30, 2026

Data Sources Report a data error